Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Arbutus Biopharma
Pharma
Moderna commits $950M upfront to resolve patent lawsuit
About four years after the case was filed, Moderna has resolved a long-running patent feud with Genevant and Arbutus. Investors celebrated the move.
Fraiser Kansteiner
Mar 4, 2026 10:33am
Arbutus, Genevant expand COVID patent feud with Moderna
Mar 4, 2025 11:49am
Arbutus, Genevant nab a pre-trial edge in Moderna patent suit
Apr 4, 2024 10:48am
Court upholds prior strike of Arbutus patent in Moderna case
Apr 12, 2023 11:44am
Arbutus, Genevant claim Pfizer patent infringement in new suit
Apr 4, 2023 11:48am
Moderna's motion to dismiss patent suit denied by federal judge
Nov 3, 2022 4:23pm
